Alan Kohler: What sort of revenue is Starpharma expecting from VivaGel sales?
CEO Jackie: ”We haven’t provided at this stage a detailed guidance in terms of the revenue numbers, as I guess we launch in more markets and as we actually have the product on the market in more markets, we will be providing guidance”
*This interview is publicly available on YouTube.
**Unfortunately for shareholders this interview was in mid 2019.
*** That was probably a fair statement by the CEO at the time. But it’s NOW loooong overdue. Seriously, three and a half years later Starpharma will still not provide any guidance on VivaGel BV sales.
In my personal opinion, this is because the CEO is EMBARRASSED.
Alan Kohler: What sort of revenue is Starpharma expecting from...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.010(9.09%) |
Mkt cap ! $50.17M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 12.0¢ | 11.0¢ | $127.2K | 1.070M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 130918 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 103000 | 3 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |